Future studies should incorporate immunohistochemical analyses of tumor-infiltrating immune cells (e.g., CD4+ and CD8+ T cells, IL-6R expression, macrophage markers) to delineate the relationship between systemic cytokine alterations and intratumoral immune activity. This evidence concerns the gene IL6R and neoplasm.